Cereno Scientific expands patent protection for epigenetic HDAC inhibitor CS1: s second patent familyCereno Scientific , a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced that the Canadian authorities issued a patent for the drug Read this story
